Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
McKinsey
Johnson and Johnson
Julphar
Fuji
UBS
Harvard Business School
Chubb

Generated: November 18, 2018

DrugPatentWatch Database Preview

Invagen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has fifty-three approved drugs.

There are two tentative approvals on INVAGEN PHARMS drugs.

Summary for Invagen Pharms
US Patents:0
Tradenames:43
Ingredients:43
NDAs:53

Drugs and US Patents for Invagen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms OLANZAPINE olanzapine TABLET;ORAL 203333-003 Mar 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Invagen Pharms TOPIRAMATE topiramate TABLET;ORAL 079162-004 Mar 27, 2009 AB RX No No ➤ Sign Up ➤ Sign Up
Invagen Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 206674-001 Feb 9, 2016 AB1 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Medtronic
Argus Health
Baxter
UBS
Daiichi Sankyo
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.